Bringing the fundamentals into focus…
Back to Zevra Therapeutics, Inc.
How Zevra Therapeutics, Inc. stacks up
ZVRA · against 470 other Healthcare companies of similar size
Profitability
99/ 100
Near the top of its peers.
Ranked #2 of 471 · scores higher than 99% of peers
Bars: peers in each 10-point band of the profitability score36 peers with a profitability score of 90–100, including ZVRA · Click a bar to see the companies
Why profitability scores 99?
Weighted metrics compared with all Healthcare companies.Mainly thanks to its operating margin, return on invested capital and return on assets, which are stronger than most Healthcare peers.
- a higher return on assets: stronger than 97% of peers. Return on assets: 19.2% vs peer median 1.7%
- a higher return on invested capital: stronger than 98% of peers. Return on invested capital: 90.0% vs peer median 4.7%
- a wider operating margin: stronger than 99% of peers. Operating margin: 60.5% vs peer median 7.1%
Metric by metric
Position: dot = ZVRA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | ZVRA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Return on invested capitalHigher is better · 446 reported | 90.0% | 2.5% | 99% | 33% | |
| Operating marginHigher is better · 444 reported | 60.5% | 4.9% | 100% | 33% | |
| Return on assetsHigher is better · 465 reported | 19.2% | 1.0% | 97% | 33% | |
| Return on equityHigher is better · 445 reported | 34.8% | 1.6% | 98% | Context only | |
| Gross marginHigher is better · 489 reported | 95.5% | 42.5% | 97% | Context only |
Ranking by profitability score
Top 5 and the companies ranked around ZVRA| Rank | Company | Market cap | Profitability | Overall |
|---|---|---|---|---|
| 1 | 97.3B INR (≈$1.2B) | 100 | 80 | |
| 2 | 595M USD | 99 | 97 | |
| 2 | 433M USD | 99 | 81 | |
| 2 | 578M USD | 99 | 73 | |
| 2 | 914M USD | 99 | 81 | |
| 2 | 609M USD | 99 | 91 | |
| 7 | 4.4B CNY (≈$611M) | 98 | 77 | |
| 7 | 12.0B SEK (≈$1.2B) | 98 | 72 | |
| 7 | 1.0B USD | 98 | 74 | |
| 7 | 5.5B NOK (≈$523M) | 98 | 71 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score